Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 4, 2007, Pages 388-403

  Gupta, Mahesh P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adrenergic receptors; Cardiac hypertrophy; Chromatin remodeling enzymes; Heart failure; Myosin heavy chain expression; Thyroid hormone

Indexed keywords

CARDIAC MYOSIN; MYOSIN HEAVY CHAIN; THYROID HORMONE;

ADRENERGIC STIMULATION; CHROMATIN; DIABETES MELLITUS; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIAC MYOSINS; CARDIOMEGALY; CHROMATIN ASSEMBLY AND DISASSEMBLY; DIABETES COMPLICATIONS; DIABETES MELLITUS; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; MYOSIN HEAVY CHAINS; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, BETA; THYROID HORMONES; TISSUE DISTRIBUTION;

EID: 34748888492     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.07.045     Document Type: Review

References (161)

1. Spann J. Functional changes in pathologic hypertrophy. In: Zak R. (Ed). Growth of the heart in health and disease (1984), Raveen Press, New York 421-466
2. Hajjar R.J., and Gwathmey J.K. Cross-bridge dynamics in human ventricular myocardium. Regulation of contractility in the failing heart. Circulation 86 (1992) 1819-1826
3. Mann D.L., Urabe Y., Kent R.L., Vinciguerra S., and Cooper G. Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium. Circ. Res. 68 (1991) 402-415
4. Shroff S.G., and Motz W. Left ventricular systolic resistance in rats with hypertension and hypertrophy. Am. J. Physiol.: Heart Circ Physiol 257 (1989) H386-H394
5. Anderson R.L., Kawas R.F., Pokrovskii M.V., Godinez G., Lee J.K., Mak J., et al. The cardiac myosin activator CK-1316719 increases myofibril ATPase activity and myocyte contractility in a rat model of heart failure. Circulation 114 Suppl. II (2006) 1440
6. James J., Martin L., Krenz M., Quatman C., Jones F., Klevitsky R., et al. Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions. Circulation 111 (2005) 2339-2346
7. Miyata S., Minobe W., Bristow M.R., and Leinwand L.A. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ. Res. 86 (2000) 386-390
8. Sucharov C.C., Helmke S.M., Langer S.J., Perryman M.B., Bristow M., and Leinwand L. The Ku protein complex interacts with YY1, is up-regulated in human heart failure, and represses alpha myosin heavy-chain gene expression. Mol. Cell. Biol. 24 (2004) 8705-8715
9. Braunwald E., and Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 102 (2000) IV14-IV23
10. Zak R. Contractile function as a determinant of muscle growth. Cell Muscle Motil. 1 (1981) 1-32
11. Harrington W.F., and Rodgers M.E. Myosin. Annu. Rev. Biochem. 53 (1984) 35-73
12. Mahdavi V., Chambers A.P., and Nadal-Ginard B. Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 2626-2630
13. Hoh J.F., McGrath P.A., and Hale P.T. Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J. Mol. Cell. Cardiol. 10 (1978) 1053-1076
14. Lyons G.E., Schiaffino S., Sassoon D., Barton P., and Buckingham M. Developmental regulation of myosin gene expression in mouse cardiac muscle. J. Cell Biol. 111 (1990) 2427-2436
15. Lompre A.M., Mercadier J.J., Wisnewsky C., Pantaloni P., d'Albis A., and Schwartz K. Species and age-dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals. Dev. Biol. 84 (1981) 286
16. Lompre A.M., Nadal-Ginard B., and Mahdavi V. Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. J. Biol. Chem. 259 (1984) 6437-6446
17. Clark Jr. W.A., Chizzonite R.A., Everett A.W., Rabinowitz M., and Zak R. Species correlations between cardiac isomyosins. A comparison of electrophoretic and immunological properties. J. Biol. Chem. 257 (1982) 5449-5454
18. Everett A.W., Clark W.A., Chizzonite R.A., and Zak R. Change in synthesis rates of alpha- and beta-myosin heavy chains in rabbit heart after treatment with thyroid hormone. J. Biol. Chem. 258 (1983) 2421-2425
19. Rupp H., and Jacob R. Myocardial transition between fast and slow-type muscle as monitored by the population of myosin isoenzymes. In: Rupp H. (Ed). The regulation of heart function (1986), Thieme Inc., New York 271-291
20. Herron T.J., Baghai M., Chaturvedi R., and Kentish J. Age dependence of isometric crossbridge cycling and myosin heavy chain isoform expression in human ventricular myocytes. (abstract). J. Biophys. 88 (2005) 482a
21. Eisenberg B.R., Edwards J.A., and Zak R. Transmural distribution of isomyosin in rabbit ventricle during maturation examined by immunofluorescence and staining for calcium-activated adenosine triphosphatase. Circ. Res. 56 (1985) 548-555
22. Bugaisky L.B., Anderson P.G., Hall R.S., and Bishop S.P. Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during cardiac hypertrophy in the rat. Circ. Res. 66 (1990) 1127-1132
23. Alpert N.R., Brosseau C., Federico A., Krenz M., Robbins J., and Warshaw D.M. Molecular mechanics of mouse cardiac myosin isoforms. Am. J. Physiol.: Heart Circ. Physiol. 283 (2002) H1446-H1454
24. Barany M. ATPase activity of myosin correlated with speed of muscle shortening. J. Gen. Physiol. 50(Suppl) (1967) 197-218
25. Herron T.J., and McDonald K.S. Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ. Res. 90 (2002) 1150-1152
26. Korte F.S., Herron T.J., Rovetto M.J., and McDonald K.S. Power output is linearly related to MHC content in rat skinned myocytes and isolated working hearts. Am. J. Physiol.: Heart Circ. Physiol. 289 (2005) H801-H812
27. Pagani E.D., and Julian F.J. Rabbit papillary muscle myosin isozymes and the velocity of muscle shortening. Circ. Res. 54 (1984) 586-594
28. VanBuren P., Harris D.E., Alpert N.R., and Warshaw D.M. Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ. Res. 77 (1995) 439-444
29. Sugiura S., Kobayakawa N., Fujita H., Momomura S., Chaen S., and Sugi H. Distinct kinetic properties of cardiac myosin isoforms revealed by in vitro studies. Adv. Exp. Med. Biol. 453 (1998) 125-130
30. Sugiura S., Kobayakawa N., Fujita H., Yamashita H., Momomura S., Chaen S., et al. Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation. Circ. Res. 82 (1998) 1029-1034
31. Krenz M., Sanbe A., Bouyer-Dalloz F., Gulick J., Klevitsky R., Hervett T.E., et al. Analysis of myosin heavy chain functionality in the heart. J. Biol. Chem. 278 (2003) 17466-17474
32. Krenz M., and Robbins J. Impact of beta-myosin heavy chain expression on cardiac function during stress. J. Am. Coll. Cardiol. 44 (2004) 2390-2397
33. Kurabayashi M., Tsuchimochi H., Komuro I., Takaku F., and Yazaki Y. Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium. J. Clin. Invest. 82 (1988) 524-531
34. Saez L.J., Gianola K.M., McNally E.M., Feghali R., Eddy R., Shows T.B., et al. Human cardiac myosin heavy chain genes and their linkage in the genome. Nucleic Acids Res. 15 (1987) 5443-5459
35. Haddad F., Bodell P.W., Qin A.X., Giger J.M., and Baldwin K.M. Role of antisense RNA in coordinating cardiac myosin heavy chain gene switching. J. Biol. Chem. 278 (2003) 37132-37138
36. Haddad F., Qin A.X., Bodell P.W., Zhang L.Y., Guo H., Giger J.M., et al. Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload. Am. J. Physiol.: Heart Circ. Physiol. 290 (2006) H2351-H2361
37. Luther H.P., Morwinski R., Wallukat G., Haase H., and Morano I. Expression of sense and naturally occurring antisense mRNA of myosin heavy chain in rat heart tissue and cultivated cardiomyocytes. J. Mol. Cell. Cardiol. 29 (1997) 27-35
38. Pandorf C.E., Haddad F., Roy R.R., Qin A.X., Edgerton V.R., and Baldwin K.M. Dynamics of myosin heavy chain gene regulation in slow skeletal muscle: role of natural antisense RNA. J. Biol. Chem. 281 (2006) 38330-38342
39. Chen C.Y., and Schwartz R.J. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol. Cell. Biol. 16 (1996) 6372-6384
40. Chen Z., Friedrich G.A., and Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev. 8 (1994) 2293-2301
41. Gupta M., Kogut P., Davis F.J., Belaguli N.S., Schwartz R.J., and Gupta M.P. Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor-1. J. Biol. Chem. 276 (2001) 10413-10422
42. Lin Q., Schwarz J., Bucana C., and Olson E.N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276 (1997) 1404-1407
43. Maeda T., Gupta M.P., and Stewart A.F. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem. Biophys. Res. Commun. 294 (2002) 791-797
44. Molkentin J.D., Lin Q., Duncan S.A., and Olson E.N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 11 (1997) 1061-1072
45. Sepulveda J.L., Belaguli N., Nigam V., Chen C.Y., Nemer M., and Schwartz R.J. GATA-4 and Nkx-2.5 coactivate Nkx-2 DNA binding targets: role for regulating early cardiac gene expression. Mol. Cell. Biol. 18 (1998) 3405-3415
46. Tanaka M., Chen Z., Bartunkova S., Yamasaki N., and Izumo S. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126 (1999) 1269-1280
47. Balza Jr. R.O., and Misra R.P. Role of the serum response factor in regulating contractile apparatus gene expression and sarcomeric integrity in cardiomyocytes. J. Biol. Chem. 281 (2006) 6498-6510
48. Gupta M., Zak R., Libermann T.A., and Gupta M.P. Tissue-restricted expression of the cardiac alpha-myosin heavy chain gene is controlled by a downstream repressor element containing a palindrome of two ets-binding sites. Mol. Cell. Biol. 18 (1998) 7243-7258
49. Gupta M., Sueblinvong V., and Gupta M.P. The single strand DNA/RNA-binding protein, Pur-B regulates serum response factor (SRF) mediated cardiac muscle gene expression. Can Physiool Pharmacol 85 (2007) 349-359
50. Aikawa R., Huggins G.S., and Snyder R.O. Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction. J. Biol. Chem. 277 (2002) 18979-18985
51. Gupta M., Sueblinvong V., Raman J., Jeevanandam V., and Gupta M.P. Single-stranded DNA-binding proteins PURalpha and PURbeta bind to a purine-rich negative regulatory element of the alpha-myosin heavy chain gene and control transcriptional and translational regulation of the gene expression. Implications in the repression of alpha-myosin heavy chain during heart failure. J. Biol. Chem. 278 (2003) 44935-44948
52. Ji J., Tsika G.L., Rindt H., Schreiber K.L., McCarthy J.J., Kelm Jr. R.J., et al. Pur{alpha} and Pur{beta} collaborate with Sp3 to negatively regulate {beta}-myosin heavy chain gene expression during skeletal muscle inactivity. Mol. Cell. Biol. 27 (2007) 1531-1543
53. Izumo S., Nadal-Ginard B., and Mahdavi V. All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science 231 (1986) 597-600
54. Morkin E. Regulation of myosin heavy chain genes in the heart. Circulation 87 (1993) 1451-1460
55. Burnside J., Darling D.S., and Chin W.W. A nuclear factor that enhances binding of thyroid hormone receptors to thyroid hormone response elements. J. Biol. Chem. 265 (1990) 2500-2504
56. Izumo S., and Mahdavi V. Thyroid hormone receptor alpha isoforms generated by alternative splicing differentially activate myosin HC gene transcription. Nature 334 (1988) 539-542
57. Klein I., and Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344 (2001) 501-509
58. Kinugawa K., Yonekura K., Ribeiro R.C., Eto Y., Aoyagi T., Baxter J.D., et al. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ. Res. 89 (2001) 591-598
59. Flink I.L., and Morkin E. Interaction of thyroid hormone receptors with strong and weak cis-acting elements in the human alpha-myosin heavy chain gene promoter. J. Biol. Chem. 265 (1990) 11233-11237
60. Tsika R.W., Bahl J.J., Leinwand L.A., and Morkin E. Thyroid hormone regulates expression of a transfected human alpha-myosin heavy-chain fusion gene in fetal rat heart cells. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 379-383
61. Baniahmad A., Steiner C., Kohne A.C., and Renkawitz R. Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Cell 61 (1990) 505-514
62. Chatterjee V.K., Lee J.K., Rentoumis A., and Jameson J.L. Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 9114-9118
63. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
64. Advani S.V., Malhotra A., Liang D., Geenen D.L., Buttrick P.M., and Scheuer J. Swimming alternates the shift in myosin isozymes in the rat heterotopic cardiac isograft. Circulation 80 suppl. II (1989) 1185
65. Dowell R.T. Myocardial contractile function and myofibrillar adenosine triphosphatase activity in chemically sympathectomized rats. Circ. Res. 39 (1976) 683-689
66. Gupta M.P., Gupta M., Stewart A., and Zak R. Activation of alpha-myosin heavy chain gene expression by cAMP in cultured fetal rat heart myocytes. Biochem. Biophys. Res. Commun. 174 (1991) 1196-1203
67. Gupta M.P., Gupta M., and Zak R. An E-box/M-CAT hybrid motif and cognate binding protein(s) regulate the basal muscle-specific and cAMP-inducible expression of the rat cardiac alpha-myosin heavy chain gene. J. Biol. Chem. 269 (1994) 29677-29687
68. Kawana M., Ischizuka S., Taria A., Kimata S., and Hosoda S. Effect of cardiac sympathetic nerve activity on myosin isoenzymes of rabbit heart. Circulation 89 Suppl. II (1989) 1893
69. Kawana M., Kimata S.I., and Hosoda S. The change in expression of cardiac myosin isoenzymes by the stimulation of the sympathetic nerve and thyroxin. In: Nagano M., Takeda N., and Dhalla N.S. (Eds). The adapted heart (1994), Raven Press, New York 393-401
70. Pauletto P., Dalla Libera L., Vescovo G., Scannapieco G., Angelini A., Pessina A.C., et al. Propranolol-induced changes in ventricular isomyosin composition in the rat. Am. Heart J. 109 (1985) 1269-1273
71. Sucharov C.C., Mariner P.D., Nunley K.R., Long C., Leinwand L., and Bristow M.R. A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am. J. Physiol.: Heart Circ. Physiol. 291 (2006) H1299-H1308
72. Winegrad S., McClellan G., Tucker M., and Lin L.E. Cyclic AMP regulation of myosin isozymes in mammalian cardiac muscle. J. Gen. Physiol. 81 (1983) 749-765
73. Winegrad S., McClellan G., Weisberg A., Lin L.E., Weindling S., and Horowits R. Beta-adrenergic regulation of cardiac myosin. Can. J. Physiol. Pharmacol. 65 (1987) 606-609
74. Winegrad S., and Weisberg A. Isozyme specific modification of myosin ATPase by cAMP in rat heart. Circ. Res. 60 (1987) 384-392
75. Winegrad S., Weisberg A., Lin L.E., and McClellan G. Adrenergic regulation of myosin adenosine triphosphatase activity. Circ. Res. 58 (1986) 83-95
76. Waspe L.E., Ordahl C.P., and Simpson P.C. The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. J. Clin. Invest. 85 (1990) 1206-1214
77. Gustafson T.A., Bahl J.J., Markham B.E., Roeske W.R., and Morkin E. Hormonal regulation of myosin heavy chain and alpha-actin gene expression in cultured fetal rat heart myocytes. J. Biol. Chem. 262 (1987) 13316-13322
78. Gupta M.P., Amin C.S., Gupta M., Hay N., and Zak R. Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol. Cell. Biol. 17 (1997) 3924-3936
79. Ojamaa K., Samarel A.M., and Klein I. Identification of a contractile-responsive element in the cardiac alpha-myosin heavy chain gene. J. Biol. Chem. 270 (1995) 31276-31281
80. Gupta M.P., Kogut P., and Gupta M. Protein kinase-A dependent phosphorylation of transcription enhancer factor-1 represses its DNA-binding activity but enhances its gene activation ability. Nucleic Acids Res. 28 (2000) 3168-3177
81. Kariya K., Karns L.R., and Simpson P.C. An enhancer core element mediates stimulation of the rat beta-myosin heavy chain promoter by an alpha 1-adrenergic agonist and activated beta-protein kinase C in hypertrophy of cardiac myocytes. J. Biol. Chem. 269 (1994) 3775-3782
82. Kariya K., Farrance I.K., and Simpson P.C. Transcriptional enhancer factor-1 in cardiac myocytes interacts with an alpha 1-adrenergic- and beta-protein kinase C-inducible element in the rat beta-myosin heavy chain promoter. J. Biol. Chem. 268 (1993) 26658-26662
83. Stewart A.F., Larkin S.B., Farrance I.K., Mar J.H., Hall D.E., and Ordahl C.P. Muscle-enriched TEF-1 isoforms bind M-CAT elements from muscle-specific promoters and differentially activate transcription. J. Biol. Chem. 269 (1994) 3147-3150
84. Karin M. Complexities of gene regulation by cAMP. Trends Genet. 5 (1989) 65-67
85. Huang M.H., Friend D.S., Sunday M.E., Singh K., Haley K., Austen K.F., et al. An intrinsic adrenergic system in mammalian heart. J. Clin. Invest. 98 (1996) 1298-1303
86. Jaber M., Koch W.J., Rockman H., Smith B., Bond R.A., Sulik K.K., et al. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 12974-12979
87. Dillmann W.H. Influence of thyroid hormone administration on myosin ATPase activity and myosin isoenzyme distribution in the heart of diabetic rats. Metabolism 31 (1982) 199-204
88. 2+-activated myosin ATPase activity and changes myosin isoenzyme distribution in the diabetic rat heart. Endocrinology 114 (1984) 1678-1685
89. 2+-activated myosin ATPase activity and changes myosin isoenzyme distribution in the diabetic rat heart. Am. J. Physiol. 248 (1985) E602-E606
90. 2+-activated myosin ATPase activity in the rat heart is influenced by fructose feeding and triiodothyronine. Endocrinology 116 (1985) 2160-2166
91. Sheer D., and Morkin E. Myosin isoenzyme expression in rat ventricle: effects of thyroid hormone analogs, catecholamines, glucocorticoids and high carbohydrate diet. J. Pharmacol. Exp. Ther. 229 (1984) 872-879
92. Jordan J.E., Simandle S.A., Tulbert C.D., Busija D.W., and Miller A.W. Fructose-fed rats are protected against ischemia/reperfusion injury. J. Pharmacol. Exp. Ther. 307 (2003) 1007-1011
93. Morano I., Gerstner J., Ruegg J.C., Ganten U., Ganten D., and Vosberg H.P. Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. Circ. Res. 66 (1990) 1585-1590
94. Dillmann W.H., Berry S., and Alexander N.M. A physiological dose of triiodothyronine normalizes cardiac myosin adenosine triphosphatase activity and changes myosin isoenzyme distribution in semistarved rats. Endocrinology 112 (1983) 2081-2087
95. Dowell R.T., and Martin A.F. Perinatal nutritional modification of weanling rat heart contractile protein. Am. J. Physiol.: Heart Circ Physiol 247 (1984) H967-H972
96. Razeghi P., Essop M.F., Huss J.M., Abbasi S., Manga N., and Taegtmeyer H. Hypoxia-induced switches of myosin heavy chain iso-gene expression in rat heart. Biochem. Biophys. Res. Commun. 303 (2003) 1024-1027
97. Rupp H. Differential effect of physical exercise routines on ventricular myosin and peripheral catecholamine stores in normotensive and spontaneously hypertensive rats. Circ. Res. 65 (1989) 370-377
98. Rupp H., Felbier H.R., Bukhari A.R., and Jacob R. Modulation of myosin isoenzyme populations and activities of monoamine oxidase and phenylethanolamine-N-methyltransferase in pressure loaded and normal rat heart by swimming exercise and stress arising from electrostimulation in pairs. Can. J. Physiol. Pharmacol. 62 (1984) 1209-1218
99. Rupp H., and Jacob R. Response of blood pressure and cardiac myosin polymorphism to swimming training in the spontaneously hypertensive rat. Can. J. Physiol. Pharmacol. 60 (1982) 1098-1103
100. Scheuer J., Malhotra A., Hirsch C., Capasso J., and Schaible T.F. Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. J. Clin. Invest. 70 (1982) 1300-1305
101. Koziris L.P., Hickson R.C., Chatterton Jr. R.T., Groseth R.T., Christie J.M., Goldflies D.G., et al. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J. Appl. Physiol. 86 (1999) 1436-1442
102. Neri Serneri G.G., Boddi M., Modesti P.A., Cecioni I., Coppo M., Padeletti L., et al. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res. 89 (2001) 977-982
103. Donath M.Y., Gosteli-Peter M.A., Hauri C., Froesch E.R., and Zapf J. Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart. Eur. J. Endocrinol. 137 (1997) 309-315
104. Litten III R.Z., Martin B.J., Low R.B., and Alpert N.R. Altered myosin isozyme patterns from pressure-overloaded and thyrotoxic hypertrophied rabbit hearts. Circ. Res. 50 (1982) 856-864
105. Lompre A.M., Schwartz K., d'Albis A., Lacombe G., Van Thiem N., and Swynghedauw B. Myosin isoenzyme redistribution in chronic heart overload. Nature 282 (1979) 105-107
106. Mercadier J.J., Lompre A.M., Wisnewsky C., Samuel J.L., Bercovici J., Swynghedauw B., et al. Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ. Res. 49 (1981) 525-532
107. Pillai J.B., Russell H.M., Raman J., Jeevanandam V., and Gupta M.P. Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure. Am. J. Physiol.: Heart Circ. Physiol. 288 (2005) H486-H496
108. 2+-ATPase and alpha-myosin heavy chain in rat hearts. J. Clin. Invest. 100 (1997) 1742-1749
109. Noguchi T., Camp Jr. P., Alix S.L., Gorga J.A., Begin K.J., Leavitt B.J., et al. Myosin from failing and non-failing human ventricles exhibit similar contractile properties. J. Mol. Cell. Cardiol. 35 (2003) 91-97
110. Herron T.J., Korte F.S., and McDonald K.S. Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am. J. Physiol.: Heart Circ. Physiol. 281 (2001) H1217-H1222
111. deGoma E.M., Vagelos R.H., Fowler M.B., and Ashley E.A. Emerging therapies for the management of decompensated heart failure: from bench to bedside. J. Am. Coll. Cardiol. 48 (2006) 2397-2409
112. Carniel E., Taylor M.R., Sinagra G., Di Lenarda A., Ku L., Fain P.R., et al. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 112 (2005) 54-59
113. Gupta M., and Zak R. Reversibility of load-induced changes in myosin heavy chain gene expression. Am. J. Physiol. 262 (1992) R346-R349
114. Wiesner R.J., Ehmke H., Faulhaber J., Zak R., and Ruegg J.C. Dissociation of left ventricular hypertrophy, beta-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis. Circulation 95 (1997) 1253-1259
115. i and contractile activity. Am. J. Physiol. 273 (1997) C394-C403
116. Nikcevic G., Heidkamp M.C., Perhonen M., and Russell B. Mechanical activity in heart regulates translation of alpha-myosin heavy chain mRNA but not its localization. Am. J. Physiol.: Heart Circ Physiol 276 (1999) H2013-H2019
117. Morkin E., Pennock G., Spooner P.H., Bahl J.J., Underhill Fox K., and Goldman S. Pilot studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure. Cardiology 97 (2002) 218-225
118. Mariner P.D., Luckey S.W., Long C.S., Sucharov C.C., and Leinwand L.A. Yin Yang 1 represses alpha-myosin heavy chain gene expression in pathologic cardiac hypertrophy. Biochem. Biophys. Res. Commun. 326 (2005) 79-86
119. Oei S.L., Griesenbeck J., Schweiger M., Babich V., Kropotov A., and Tomilin N. Interaction of the transcription factor YY1 with human poly(ADP-ribosyl) transferase. Biochem. Biophys. Res. Commun. 240 (1997) 108-111
120. Zambrano N., De Renzis S., Minopoli G., Faraonio R., Donini V., Scaloni A., et al. DNA-binding protein Pur alpha and transcription factor YY1 function as transcription activators of the neuron-specific FE65 gene promoter. Biochem. J. 328 Pt 1 (1997) 293-300
121. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93 (1998) 215-228
122. Stewart A.F., Suzow J., Kubota T., Ueyama T., and Chen H.H. Transcription factor RTEF-1 mediates alpha1-adrenergic reactivation of the fetal gene program in cardiac myocytes. Circ. Res. 83 (1998) 43-49
123. Bisping E., Ikeda S., Kong S.W., Tarnavski O., Bodyak N., McMullen J.R., et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14471-14476
124. McLean B.G., Lee K.S., Simpson P.C., and Farrance I.K. Basal and alpha1-adrenergic-induced activity of minimal rat betaMHC promoters in cardiac myocytes requires multiple TEF-1 but not NFAT binding sites. J. Mol. Cell. Cardiol. 35 (2003) 461-471
125. de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., and van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370 (2003) 737-749
126. Backs J., and Olson E.N. Control of cardiac growth by histone acetylation/deacetylation. Circ. Res. 98 (2006) 15-24
127. Davis F.J., Gupta M., Camoretti-Mercado B., Schwartz R.J., and Gupta M.P. Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy. J. Biol. Chem. 278 (2003) 20047-20058
128. McKinsey T.A., Zhang C.L., and Olson E.N. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 14400-14405
129. Davis F.J., Pillai J.B., Gupta M., and Gupta M.P. Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility. Am. J. Physiol.: Heart Circ. Physiol. 288 (2005) H1477-H1490
130. Kong Y., Tannous P., Lu G., Berenji K., Rothermel B.A., Olson E.N., et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113 (2006) 2579-2588
131. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., and Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110 (2002) 479-488
132. Danzi S., Dubon P., and Klein I. Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation. Am. J. Physiol.: Heart Circ. Physiol. 289 (2005) H1506-H1511
133. Wu Y., and Koenig R.J. Gene regulation by thyroid hormone. Trends Endocrinol. Metab. 11 (2000) 207-211
134. Pacher P., Schulz R., Liaudet L., and Szabo C. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol. Sci. 26 (2005) 302-310
135. Pillai J.B., Gupta M., Rajamohan S.B., Lang R., Raman J., and Gupta M.P. Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. Am. J. Physiol.: Heart Circ. Physiol. 291 (2006) H1545-H1553
136. Butler A.J., and Ordahl C.P. Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol. Cell. Biol. 19 (1999) 296-306
137. Vyas D.R., McCarthy J.J., Tsika G.L., and Tsika R.W. Multiprotein complex formation at the beta myosin heavy chain distal muscle CAT element correlates with slow muscle expression but not mechanical overload responsiveness. J. Biol. Chem. 276 (2001) 1173-1184
138. Xiao C.Y., Chen M., Zsengeller Z., Li H., Kiss L., Kollai M., et al. Poly(ADP-ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure. J. Pharmacol. Exp. Ther. 312 (2005) 891-898
139. + depletion and reduced Sir2alpha deacetylase activity. J. Biol. Chem. 280 (2005) 43121-43130
140. Cohenrmon-Armon M., Visochek L., Rozensal D., Kalal A., Geistrikh I., Klein R., et al. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol. Cell 25 (2007) 297-308
141. Homburg S., Visochek L., Moran N., Dantzer F., Priel E., Asculai E., et al. A fast signal-induced activation of poly(ADP-ribose) polymerase: a novel downstream target of phospholipase c. J. Cell Biol. 150 (2000) 293-307
142. Hassa P.O., Haenni S.S., Buerki C., Meier N.I., Lane W.S., Owen H., et al. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J. Biol. Chem. 280 (2005) 40450-40464
143. Poirier G.G., de Murcia G., Jongstra-Bilen J., Niedergang C., and Mandel P. Poly(ADP-ribosyl)ation of polynucleosomes causes relaxation of chromatin structure. Proc. Natl. Acad. Sci. U. S. A. 79 (1982) 3423-3427
144. Chen I.Y., Lypowy J., Pain J., Sayed D., Grinberg S., Alcendor R.R., et al. Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2alpha. J. Biol. Chem. 281 (2006) 19369-19377
145. Schreiber V., Dantzer F., Ame J.C., and de Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev., Mol. Cell Biol. 7 (2006) 517-528
146. Szabo G., Liaudet L., Hagl S., and Szabo C. Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc. Res. 61 (2004) 471-480
147. Kloosterman W.P., and Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 11 (2006) 441-450
148. Lagos-Quintana M., Rauhut R., Meyer J., Borkhardt A., and Tuschl T. New microRNAs from mouse and human. RNA 9 (2003) 175-179
149. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., and Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316 (2007) 575-579
150. Blander G., and Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73 (2004) 417-435
151. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305 (2004) 390-392
152. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23 (2004) 2369-2380
153. Zhang J. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?. BioEssays 25 (2003) 808-914
154. Everett A.W., Sinha A.M., Umeda P.K., Jakovcic S., Rabinowitz M., and Zak R. Regulation of myosin synthesis by thyroid hormone: relative change in the alpha- and beta-myosin heavy chain mRNA levels in rabbit heart. Biochemistry 23 (1984) 1596-1599
155. Molkentin J.D., Jobe S.M., and Markham B.E. Alpha-myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter. J. Mol. Cell. Cardiol. 28 (1996) 1211-1225
156. Molkentin J.D., Kalvakolanu D.V., and Markham B.E. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene. Mol. Cell. Biol. 14 (1994) 4947-4957
157. Molkentin J.D., and Markham B.E. Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo. J. Biol. Chem. 268 (1993) 19512-19520
158. Gupta M.P., Gupta M., Zak R., and Sukhatme V.P. Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac alpha-myosin heavy chain gene. J. Biol. Chem. 266 (1991) 12813-12816
159. Huang W.Y., Chen J.J., Shih N., and Liew C.C. Multiple muscle-specific regulatory elements are associated with a DNase I hypersensitive site of the cardiac beta-myosin heavy-chain gene. Biochem. J. 327 Pt 2 (1997) 507-512
160. Hasegawa K., Lee S.J., Jobe S.M., Markham B.E., and Kitsis R.N. cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation 96 (1997) 3943-3953
161. von Harsdorf R., Edwards J.G., Shen Y.T., Kudej R.K., Dietz R., Leinwand L.A., et al. Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload. J. Clin. Invest. 100 (1997) 1294-1304